1. Home
  2. ORIO vs TVGN Comparison

ORIO vs TVGN Comparison

Compare ORIO & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Digital Corp. Common Shares

ORIO

Orion Digital Corp. Common Shares

N/A

Current Price

$0.98

Market Cap

20.5M

Sector

N/A

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$7.32

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ORIO
TVGN
Founded
N/A
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
21.3M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
ORIO
TVGN
Price
$0.98
$7.32
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
83.2K
4.1K
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$74.52
N/A
Revenue Next Year
$5.07
N/A
P/E Ratio
$4.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.14
52 Week High
$1.40
$12.03

Technical Indicators

Market Signals
Indicator
ORIO
TVGN
Relative Strength Index (RSI) 57.80 62.41
Support Level $0.82 $6.41
Resistance Level $1.12 $7.42
Average True Range (ATR) 0.10 0.32
MACD 0.01 0.05
Stochastic Oscillator 56.58 100.00

Price Performance

Historical Comparison
ORIO
TVGN

About ORIO Orion Digital Corp. Common Shares

Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: